Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied. Probenecid is a substrate and inhibitor of OAT. No interaction is expected with emtricitabine as it is eliminated by different renal transporters. However, coadministration could increase tenofovir concentrations as OAT is involved in the excretion of tenofovir.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking